Stories from MedEsthetics
Friday, December 29, 2017 - 11:54
FEATURES Foods and supplements that support skin health »Eating for Beautiful Skin
Friday, December 29, 2017 - 10:13
The U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) from Allergan to review Seysara (sarecycline) for the treatment of moderate to severe acne vulgaris in patients nine years of age and older. Seysara is a once daily, oral, narrow spectrum tetracycline-derived antibiotic with anti-inflammatory properties.
Friday, December 29, 2017 - 10:11
STRATA Skin Sciences, a medical technology company in dermatology and plastic surgery, announced that LuAnn Via, current board member and chair of the compensation committee, has been unanimously appointed as chairperson of the board. The STRATA board made the appointment after current chairperson Jeffrey O’Donnell, Sr., decided to step down due to other commitments.
Friday, December 29, 2017 - 10:10
In an effort to better understand the molecular changes that lead to visible skin aging, researchers at Massachusetts General Hospital, Harvard School of Medicine conducted histologic and transcriptomics profiling of skin biopsies from 158 Caucasian women ages 20 to 74 years. Alexa B. Kimball, MD, et al, compared skin biopsy samples of photoexposed (face and dorsal forearm) or photoprotected (buttocks) body sites and used 23andMe genotyping determined genetic ancestry of the subjects. They noted that some of the women appeared substantially younger than their chronological age.
Friday, December 29, 2017 - 09:43
Foods and supplements that support skin health.Heather LarsonWhether a patient presents with acne, wrinkles or brown spots, traditional treatments have skewed toward topical remedies and devices, but aesthetic professionals can help patients achieve optimal outcomes—and improve their overall health—by understanding the role that certain foods play in reducing or exacerbating common skin concerns.
Friday, December 15, 2017 - 12:39
The addition of platelet-rich plasma (PRP) to fat grafts appears to increase longevity of the transplanted materials, but inconsistent preparation protocols make meaningful evaluation of outcomes difficult, according to a retrospective study published online in Plastic and Reconstructive Surgery—Global Open (December 6, 2017).
Friday, December 15, 2017 - 12:37
The U.S. Food and Drug Administration (FDA) has cleared Coolsculpting cryolipolysis treatment (Allergan) for improved appearance of lax tissue in conjunction with submental fat, or double chin, treatments. An 18-week clinical study of Coolsculpting using the CoolMini applicator for the treatment of submental fat found that 77 percent of patients showed improved appearance of lax tissue and 75 percent of patients reported their chins looked more toned following treatment.
Friday, December 15, 2017 - 12:35
eRelevance Corporation, an automated marketing service for small- to medium-size businesses, has hired John Finocchiaro as vice president of inside sales. Finocchiaro, who will lead and continue to build an inside sales team focused on tripling sales of the eRelevance customer marketing service over the next 12 months, brings 15 years experience to the position. Most recently, he was senior manager at Dude Sales. Prior to that, he served as VP of inside sales at Knowledge Tree.
Friday, December 15, 2017 - 12:32
Restoration Robotics, maker of the Artas Hair Restoration System, has announced that Mark L. Hair will join the company as chief financial officer, effective January 5, 2018. Hair brings more than 20 years of executive management, financial advisory, consulting, and public company experience to the position. Most recently, he served as vice president and chief accounting officer at ZELTIQ Aesthetics, where he was responsible for managing the company’s global accounting organization. Prior to ZELTIQ, he served as V.P. of finance at Accuray, as a private consultant for St.
Thursday, December 7, 2017 - 10:49
Revance Therapeutics’ DaxibotulinumtoxinA for Injection (RT002) achieved six-month duration in two pivotal SAKURA Phase 3 clinical studies for the treatment of glabellar lines. RT002 met its primary composite endpoint by delivering highly statistically significant improvement against placebo in reducing the severity of glabellar lines in both SAKURA 1 and SAKURA 2.
Thursday, December 7, 2017 - 10:46
The results of a national online survey of 1,010 teenagers (ages 15-19) revealed that acne has a negative impact on body image and self-esteem, leading to anxiety over using social media. Cutanea Life Sciences commissioned the survey, which was conducted by Harris Poll.
Thursday, December 7, 2017 - 10:44
The U.S. Food and Drug Administration (FDA) has cleared the DESCRIBE PFD Patch (Merz Aesthetics), a single-use, perfluorodecalin-infused clear patch used during laser treatment of tattoos, for all commonly used wavelengths for tattoo removal. The Patch, which is placed over tattoos prior to treatment, allows practitioners to perform rapid multiple laser passes in a single treatment session. It was previously cleared in April 2015 for use with the 755nm QS Alexandrite laser, which is effective in removal of tattoos with blue or black ink.
Thursday, December 7, 2017 - 10:41
Modernizing Medicine, a provider a specialty-specific, data-driven and cloud-based electronic health record (EHR) systems, is launching two new initiatives to better support providers and patients. The company is now working with OptimizeRX, which notifies healthcare providers (HCPs) of potential prescription savings and support information for their patients, and Xcertia, a collaborative dedicated to improving the quality, safety and effectiveness of mobile health applications, or apps.
Thursday, November 30, 2017 - 10:36
Soft tissue fillers are popular and effective tools for replacing lost volume in the face. The most common adverse event is bruising, particularly in patients who require injections to multiple areas. In an effort to reduce filler-related bruising, Hasan Galadari, MD, and Wolfgang Redka-Swoboda, MD, have developed a technique that allows practitioners to fill the cheek and tear trough through a single entry point injection site.
Thursday, November 30, 2017 - 10:33
Fat grafting offers reliable and lasting improvement for patients seeking chin augmentation, according to a new study published in Plastic and Reconstructive Surgery (December 2017). Filipe V. Basile, MD, and Antonio Roberto Basile, MD, plastic surgeons in Ribeirao Preto-SP, Brazil, performed a prospective study that included 42 patients: 32 women and 10 men (average age 28 years).
Thursday, November 30, 2017 - 10:31
Establishment Labs, maker of the Motiva implant for breast augmentation, and OBP Medical, creator of the ONETRAC Retractors, worked together to create the Motiva Ultralight LED, a single-use, cordless surgical retractor and measurement device with integrated light source and smoke evacuator developed specifically for use with Motiva implants. The retractors, which will be included in surgical kits for the Motiva implants, help to improve clinical efficiency and reduce the risk of infection and require no assembly or fiber optic cables.
Wednesday, November 29, 2017 - 13:12
Recent court rulings may be opening the door for the importation of FDA-approved drugs from abroad.By Alex R. Thiersch, JDOperating a medical aesthetic practice is expensive, and profit margins can be precarious, particularly when a business is in its beginning stages. It’s no surprise, therefore, that practice owners are always on the lookout for ways to save money. Some do this by engaging in a practice known as parallel importation—importing non-counterfeit products from another country—which allows them to save money on brand name drugs. As tempting as it sounds, parallel importation is...
Monday, November 27, 2017 - 09:12
The U.S. Food and Drug Administration has issued an alert reminding dermatologists, plastic surgeons and consumers that injectable silicone is not approved to enhance or augment the body. In a statement released on November 14, 2017, the agency warns that such use can lead to ongoing pain, infections, and serious injuries, such as scarring and permanent disfigurement, embolism, stroke and death.